This diverse collection of papers attempts to address and discuss critically issues surrounding the control of, and access to, genetic information from ethical, medical, legal and theoretical points of view. Special reference is made to the implications of genetic information for eugenics, the insurance industry, commercialisation of genetic testing, strategies for raising public awareness and the value of theoretical, ethical and socialogical frameworks in the debate.